Navigation Links
Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results
Date:5/7/2009

arter of 2008, there is a lack of comparability in the per share amounts between the 2009 and 2008 periods presented.

                          CADENCE PHARMACEUTICALS, INC.
                          (a development stage company)
                             CONDENSED BALANCE SHEETS

                                                     March 31,   December 31,
                                                       2009          2008
                                                   (unaudited)
                      Assets
    Current assets:
      Cash and cash equivalents
                                                  $118,549,004   $47,627,246
      Restricted cash                                1,847,848     2,195,696
      Prepaid expenses and other current assets        312,801       219,674
        Total current assets                       120,709,653    50,042,616

    Property and equipment, net                      4,376,590     4,477,020
    Restricted cash                                    537,586       537,586
    Other assets                                        57,673        90,792
        Total assets                              $125,681,502   $55,148,014

            Liabilities and Stockholders' Equity
    Current liabilities:
      Accounts payable                              $3,542,647    $4,877,854
      Accrued liabilities                            5,814,540     9,063,310
      Current portion of long-term debt              7,045,605     7,694,173
      Current current liabilities                       22,048        22,048
        Total current liabilities                   16,424,840    21,657,385

    Deferred rent                                      876,724       952,274
    Long-term debt, less current portion and
     discount                                        4,653,728     6,098,113
    Total stockholders' equity                     103,726,210    26,44
'/>"/>
SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Cadence Pharmaceuticals CEO Ted Schroeder to Present at Two Investment Conferences During the Month of May 2009
2. Cadence Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences
3. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at BioCentury Publications Inc. Future Leaders in the Biotech Industry Conference in New York on April 2, 2009
4. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2008 Financial Results and Corporate Update on March 12, 2009
5. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference
6. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and Provide a Clinical Program Update on November 6, 2008
7. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the BIOCOM Investor Conference
8. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the JMP Securities Third Annual Healthcare Focus Conference
9. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the 2008 NewsMakers In the Biotech Industry Conference
10. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Two Investment Conferences During the Month of August 2008
11. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Leerink Swann Pain Roundtable Conference on June 23, 2008 in New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Applying a well-known optical phenomenon called thin-film ... has demonstrated the ability to "paint" ultra-thin coatings ... promise for making future, flexible electronic devices, creating ... next-gen rocket ships and spacecraft with extremely lightweight ... in water, it becomes iridescent, revealing a myriad ...
(Date:9/30/2014)... YORK , Sept. 30, 2014 ... and segments with highest potential revenues Do you ... updated report gives you revenue predictions for those ... For those therapies you find financial data, R&D ... analysis you get sales forecasts to 2024 at ...
(Date:9/30/2014)... Proove Biosciences , the commercial and research leader in ... test built upon research from their published P.A.I.N. Study. ... physicians with an objective way to understand theirs patient’s ... individuals. With this new test, physicians will be able ... that will affect their pain tolerance. , The P.A.I.N. ...
(Date:9/30/2014)... , September 30, 2014 ... intuitive browsing of chemistry in documents ... software solutions and consulting services for life science ... information and generate Markush structures from documents. ... organizations intellectual property, however generating and understanding Markush ...
Breaking Biology Technology:Taking thin films to the extreme 2Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 2Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 3Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 4Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 5Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 2Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 3ChemAxon Introduces ChemCurator for Chemical Information Extraction and Markush Structure Creation 2
... Patient wait times down; use of resources, accuracy and new patient ... ... HOUSTON, June 6 A new oncology practice management,model adapted ... access to advanced cancer care,while improving efficiency., The model, developed ...
... SOMERVILLE, N.J., June 6 ETHICON, INC. today ... of recombinant,human platelet-derived growth factor indicated as an ... ulcers., The WARNINGS section of the label ... a description of the epidemiologic data that is ...
... poultry processing ... line, including post-chill., SHREVEPORT, La., June ... that,poultry processing plants using FreshFx to acidify the scalder water ... adding FreshFx to the scalder can result in pathogen,reduction, but ...
Cached Biology Technology:US Oncology Manufacturing-Inspired Practice Management Model Producing Quality and Efficiency Improvements 2US Oncology Manufacturing-Inspired Practice Management Model Producing Quality and Efficiency Improvements 3US Oncology Manufacturing-Inspired Practice Management Model Producing Quality and Efficiency Improvements 4ETHICON, INC. Announces Revised Label For REGRANEX(R) (becaplermin) Gel 0.01% 2FreshFx(R) in Scalder Reduces Pathogens in Evisceration 2FreshFx(R) in Scalder Reduces Pathogens in Evisceration 3
(Date:9/30/2014)... threats in today,s ocean. From overfishing and pollution ... ecosystems are disappearing at unprecedented rates around the ... surrounding the island of Moorea in French Polynesia ... coral guard-crabs. New research from the National Museum ... McKeon and the museum,s predoctoral fellow Jenna Moore ...
(Date:9/29/2014)... bacteria called Clostridium ramosum , coupled with a high-fat ... published this week in mBio , the online open-access ... research team from the German Institute of Human Nutrition Potsdam-Rehbruecke ... C. ramosum gained weight when fed a high-fat ... were less obese even when consuming a high-fat diet, and ...
(Date:9/29/2014)... 1970 and 2010 populations of mammals, birds, reptiles, ... percent, says the 2014 Living Planet Report released ... loss occurs disproportionately in low-income countriesand correlates with ... In addition to the precipitous decline in wildlife ... signs about the overall health of the planet. ...
Breaking Biology News(10 mins):Smithsonian scientists discover coral's best defender against an army of sea stars 2Gut bacteria promote obesity in mice 2Half of global wildlife lost, says new WWF report 2
... suggests that the prolonged fatigue after mild exercise that ... is distinct from the inherent muscle weakness caused by ... in Nature Advance Online Publication Oct. 26, ... exercise-induced fatigue in mouse models of muscular dystrophy. Moreover, ...
... use flower scent to guide their nest-mates to good ... of London. For any animal, finding food on ... animals such as bees reduce these problems by informing ... the search. Honeybees use their waggle-dance to tell ...
... for the Rockot launcher that shall carry ESA,s GOCE ... of a failure in the guidance and navigation system ... anomaly was discovered during the spacecraft,s launch preparation tests ... to the postponement of the launch. , The cause ...
Cached Biology News:Study may explain exercise-induced fatigue in muscular dystrophies 2Study may explain exercise-induced fatigue in muscular dystrophies 3
... (MOPS Buffered) has been developed specifically for ... solution. HRP Stabilizer prevents the loss ... of the antibody or protein antigen portion ... at 0.2 microns., ,Contents: Aqueous, protein-containing ...
384 Well PCR Plate Carrier for Thermo-Sealer...
... strength adhesive system which facilitates the easy removal ... either side of the frame are of differing ... has an easy release adhesive whereas the reverse, ... bond. This means that when the coverslip is ...
These 18x18 square No.1 Corning cover glasses are made from No. 0211 zinc titania glass and are 0.16 to 0.19mm thick....
Biology Products: